Peter Ang

2.6k total citations
57 papers, 1.6k citations indexed

About

Peter Ang is a scholar working on Oncology, Genetics and Molecular Biology. According to data from OpenAlex, Peter Ang has authored 57 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Oncology, 22 papers in Genetics and 17 papers in Molecular Biology. Recurrent topics in Peter Ang's work include BRCA gene mutations in cancer (13 papers), Lung Cancer Treatments and Mutations (7 papers) and HER2/EGFR in Cancer Research (6 papers). Peter Ang is often cited by papers focused on BRCA gene mutations in cancer (13 papers), Lung Cancer Treatments and Mutations (7 papers) and HER2/EGFR in Cancer Research (6 papers). Peter Ang collaborates with scholars based in Singapore, United States and Japan. Peter Ang's co-authors include Balram Chowbay, Zee Wan Wong, Suman Lal, Edmund J.D. Lee, Edwin Sandanaraj, Yoon Sim Yap, Nan Soon Wong, Ann S. G. Lee, Puay Hoon Tan and Swan Swan Leong and has published in prestigious journals such as Journal of Clinical Oncology, PLoS ONE and Cancer Research.

In The Last Decade

Peter Ang

57 papers receiving 1.5k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Peter Ang Singapore 21 730 469 357 225 214 57 1.6k
Dirk Behringer Germany 27 1.1k 1.5× 630 1.3× 116 0.3× 388 1.7× 204 1.0× 69 2.2k
Yuichi Takatsuka Japan 22 940 1.3× 306 0.7× 371 1.0× 261 1.2× 707 3.3× 91 1.7k
Vicente Guillém Spain 18 1.2k 1.7× 374 0.8× 145 0.4× 642 2.9× 394 1.8× 52 2.0k
M Francoual France 28 1.5k 2.1× 729 1.6× 137 0.4× 682 3.0× 327 1.5× 60 2.2k
Paul R. Kucera United States 17 1.1k 1.5× 573 1.2× 201 0.6× 225 1.0× 252 1.2× 32 3.3k
Marie‐Christine Mathieu France 25 978 1.3× 461 1.0× 212 0.6× 403 1.8× 705 3.3× 63 2.1k
Zlatko P. Pavelić United States 27 899 1.2× 778 1.7× 162 0.5× 237 1.1× 477 2.2× 75 1.9k
Cecilia Nisticò Italy 23 1.2k 1.6× 306 0.7× 228 0.6× 403 1.8× 555 2.6× 70 1.6k
Selim Nasser Lebanon 14 604 0.8× 471 1.0× 90 0.3× 114 0.5× 144 0.7× 44 1.4k
Lourdes Calvo Spain 23 1.2k 1.7× 518 1.1× 246 0.7× 344 1.5× 1.1k 5.1× 102 2.0k

Countries citing papers authored by Peter Ang

Since Specialization
Citations

This map shows the geographic impact of Peter Ang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peter Ang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peter Ang more than expected).

Fields of papers citing papers by Peter Ang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Peter Ang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peter Ang. The network helps show where Peter Ang may publish in the future.

Co-authorship network of co-authors of Peter Ang

This figure shows the co-authorship network connecting the top 25 collaborators of Peter Ang. A scholar is included among the top collaborators of Peter Ang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Peter Ang. Peter Ang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Munusamy, Prabhakaran, Hai Yang Law, Seung-Chul Yoon, et al.. (2017). Identification of Novel Breast Cancer Risk Loci. Cancer Research. 77(19). 5428–5437. 11 indexed citations
2.
Lal, Sunil K., London Lucien Ooi, Zee Wan Wong, et al.. (2016). Pharmacogenetics of ABCB5, ABCC5 and RLIP76 and doxorubicin pharmacokinetics in Asian breast cancer patients. The Pharmacogenomics Journal. 17(4). 337–343. 20 indexed citations
3.
Lim, Joanne, Thomas Muerdter, Onkar Singh, et al.. (2016). Pharmacogenetics of UGT1A4, UGT2B7 and UGT2B15 and Their Influence on Tamoxifen Disposition in Asian Breast Cancer Patients. Clinical Pharmacokinetics. 55(10). 1239–1250. 24 indexed citations
4.
Hong, Lewis Z., Toomas Silla, Vikrant Kumar, et al.. (2015). Predictive Factors for BRCA1 and BRCA2 Genetic Testing in an Asian Clinic-Based Population. PLoS ONE. 10(7). e0134408–e0134408. 16 indexed citations
5.
Yeo, Zhen Xuan, Maurice Chan, Yoon Sim Yap, et al.. (2012). Improving Indel Detection Specificity of the Ion Torrent PGM Benchtop Sequencer. PLoS ONE. 7(9). e45798–e45798. 44 indexed citations
6.
Chan, Maurice, Shen Ji, Yoon Sim Yap, et al.. (2012). Association of common genetic variants with breast cancer risk and clinicopathological characteristics in a Chinese population. Breast Cancer Research and Treatment. 136(1). 209–220. 45 indexed citations
7.
Chan, Maurice, Hai Yang Law, Seung-Chul Yoon, et al.. (2011). Evaluation of Nanofluidics Technology for High-Throughput SNP Genotyping in a Clinical Setting. Journal of Molecular Diagnostics. 13(3). 305–312. 22 indexed citations
8.
Lim, Wan‐Teck, E.H. Tan, Chee‐Keong Toh, et al.. (2009). Phase I pharmacokinetic study of a weekly liposomal paclitaxel formulation (Genexol®-PM) in patients with solid tumors. Annals of Oncology. 21(2). 382–388. 116 indexed citations
9.
Lal, Suman, Zee Wan Wong, Edwin Sandanaraj, et al.. (2008). Influence of ABCB1 and ABCG2 polymorphisms on doxorubicin disposition in Asian breast cancer patients. Cancer Science. 99(4). 816–823. 113 indexed citations
10.
Lal, Suman, Edwin Sandanaraj, Zee Wan Wong, et al.. (2008). CBR1andCBR3pharmacogenetics and their influence on doxorubicin disposition in Asian breast cancer patients. Cancer Science. 99(10). 2045–2054. 57 indexed citations
11.
Ang, Peter, et al.. (2006). Breast carcinoma in women 35 years and younger: a pathological study. Pathology. 38(3). 219–222. 28 indexed citations
12.
Lim, Yen Loo, et al.. (2006). Toxic epidermal necrolysis in patient with breast cancer receiving letrozole. The Lancet Oncology. 7(2). 184–185. 1 indexed citations
13.
Goh, Chee Leok, et al.. (2005). Characteristics of Hori naevus: a prospective analysis. British Journal of Dermatology. 154(1). 50–53. 37 indexed citations
14.
Leong, Swan Swan, Kam Weng Fong, Yew Kwang Ong, et al.. (2004). Chemo-radiotherapy for stage III unresectable non-small cell lung cancer—long-term results of a prospective study. Respiratory Medicine. 98(11). 1080–1086. 6 indexed citations
15.
Lee, Shoei‐Sheng, et al.. (2003). Clinical profile and treatment outcome of livedoid vasculitis: a case series.. PubMed. 32(6). 835–9. 17 indexed citations
16.
Ang, Peter, et al.. (2001). Primary Intrathoracic Malignant Effusion. CHEST Journal. 120(1). 50–54. 14 indexed citations
17.
Ang, Peter. (2001). Genetic susceptibility for breast cancer?Risk assessment and counseling. Seminars in Oncology. 28(4). 419–433. 17 indexed citations
18.
Ang, Peter, et al.. (2000). Pseudomembranous Colitis in a Patient Treated with Paclitaxel for Carcinoma of the Breast: A Case Report. Annals of the Academy of Medicine Singapore. 29(1). 132–132. 6 indexed citations
19.
Ang, Peter, et al.. (2000). Use of a peripherally implanted subcutaneous permanent central venous access device for chemotherapy – the Singapore General Hospital experience. Australian and New Zealand Journal of Medicine. 30(4). 470–474. 8 indexed citations
20.
Ang, Peter. (1998). Sunscreen allergy in Singapore. American Journal of Contact Dermatitis. 9(1). 42–44. 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Dirk Behringer Breakdown of academic impact, for papers by Yuichi Takatsuka Breakdown of academic impact, for papers by Vicente Guillém Breakdown of academic impact, for papers by M Francoual Breakdown of academic impact, for papers by Paul R. Kucera Breakdown of academic impact, for papers by Marie‐Christine Mathieu Breakdown of academic impact, for papers by Zlatko P. Pavelić Breakdown of academic impact, for papers by Cecilia Nisticò Breakdown of academic impact, for papers by Selim Nasser Breakdown of academic impact, for papers by Lourdes Calvo
Rankless by CCL
2026